Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Bringing together unparalleled healthcare data, advanced analytics, innovative technologies, and healthcare expertise to create intelligent connections that speed the development and commercialization of innovative medicines to improve patient lives.
Learn MoreAccelerate digital innovation to enable smarter decisions that reduce cost, modernize patient and consumer engagement, and improve health outcomes.
Learn MoreYour world is unique – and quite different from pharma. In the U.S., decision-making has shifted from individual physicians to integrated networks--GPOs, IDNs and payers. These groups have heightened the focus on proving your solution’s value, demanding outcomes analyses and putting pressure on pricing.
Learn MoreFor government agencies and organizations at every level—from federal or national to regional and local—Big Data can have a huge impact on public health.
Learn MoreA curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the United States healthcare market.
LEARN MOREGet the latest insights on our life sciences, healthcare, and medical technology solutions in the United States. Follow our blog today!
LEARN MOREHealthcare legislation and market trends are continually evolving. Over the past few decades, we have seen the emergence of multi-indication blockbuster therapies and an increased focus on lifecycle management (LCM), which has driven a much different market access landscape than the “primary care days”.
This webinar will help you evolve your LCM strategy with the changing times by analyzing effective market access LCM strategies from the past, evaluating how strategies are expected to change, and identifying which questions Value and Access teams should ask to prepare for success.
Key objectives:
Paul Villa
Sr. Principal, Value & Access Strategy Consulting, IQVIA
Haejin Shin
Principal, Value & Access Strategy Consulting, IQVIA
